Home   >  
GPCR/G Protein
  • Wnt/Stem Cell

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
8-Bromo-cAMP sodium salt Chemical Structure
BCP20617 8-Bromo-cAMP sodium salt 76939-46-3
8-Bromo-cAMP is a cell perbeable cyclic AMP (cAMP) analog and a PKA activator.
PKA Inhibitor (5-24) Chemical Structure
BCP35218 PKA Inhibitor (5-24) 99534-03-9
PKA Inhibitor (5-24) is a potent, competitive, and synthetic peptide inhibitor of PKA (cAMP-dependent protein kinase), with a Ki of 2.3 nM. PKI(5-24) corresponds to residues 5-24 in the naturally occurring heat-stable protein kinase inhibitor.
AT7867 dihydrochloride Chemical Structure
BCP30936 AT7867 dihydrochloride 1431697-86-7
AT7867 dihydrochloride is a potent ATP-competitive inhibitor of Akt1/Akt2/Akt3 and p70S6K/PKA with IC50s of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively.
Rp-8-bromo-Cyclic AMPS sodium salt Chemical Structure
BCP29965 Rp-8-bromo-Cyclic AMPS sodium salt 925456-59-3
Rp-8-bromo-Cyclic AMPS (Rp-8-bromo-cAMPS) is a cell-permeable cAMP analog that combines an exocyclic sulfur substitution in the equatorial position of the cyclophosphate ring with a bromine substitution in the adenine base of cAMP.
TX-1918 Chemical Structure
BCP16358 TX-1918 503473-32-3
TX-1918 is a cell-permeable tyrphostin derivative that inhibits eukaryotic elongation factor-2 kinase (eEF-2K; IC50 = 440 nM).
Fasudil Chemical Structure
BCP26821 Fasudil 103745-39-7
Fasudil, a Rho-kinase inhibitor, has been shown to reduce portal venous pressure in cirrhotic rats.
Fasudil hydrochloride Chemical Structure
BCP26351 Fasudil hydrochloride 105628-07-7
Fasudil Hydrochloride is a potent inhibitor of ROCK1, PKA, PKC, and MLCK with Kis of 0.33 μM, 1.0 μM, 9.3 μM and 55 μM, respectively.
Dibutyryl adenosine cyclophosphate calcium Chemical Structure
BCP23536 Dibutyryl adenosine cyclophosphate calcium 938448-87-4
Bucladesine calcium salt(DC2797 calcium salt) is a membrane permeable selective activator of PKA.
CCG215022 Chemical Structure
BCP18562 CCG215022 1813527-81-9
CCG215022 is a potent GRK2 and GRK5 inhibitor. CCG215022 exhibited nanomolar IC50 values against both GRK2 and GRK5 and good selectivity against other closely related kinases such as GRK1 and PKA.
AT13148 Chemical Structure
BCP08961 AT13148 1056901-62-2
AT13148 is a novel oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity
12下一頁共 15 條記錄 1 / 2 頁 
福建36选7奖金 一期一码最准期期中 救济金6元棋牌斗地主 免费麻将 快乐10分口诀 内蒙古快三3开奖直播 二分彩开奖结果查询 天天乐app下载 免费下载闲来麻将 _网上百家乐赌场 江苏快3下载app 浙江快乐12走势图 今日3d专家预测号码 河北快三和值玩法 江西十一选五走势图360 花麻将打法技巧 内蒙古十一选五最大遗漏